The world cup has been covering up logos that are not official sponsors and brands have started taking advantage of the reverse marketing,
https://t.co/YeiYuvDXIk
This move from FIFA has led to huge brands like Levis and Gillette taking advantage by changing their profile picture to its logo but covered up and even driving a van around saying 'Definetely not Levis'
https://t.co/TKVvgM1szw
This sort of reverse marketing is something we have never seen before and the attention on this is only getting bigger
(https://t.co/u69gDh5cKr)
let's cover the memecoin ███
Trulieve just became the first U.S. Marijuana Stock to officially trade on the NYSE
This is a historic first for the Marijuana industry
Best narrative is ATH... All Time High
Article:https://t.co/HISje8ehuZ
A U.S. cannabis company has joined the New York Stock Exchange for the first time in history. Trulieve, a Florida-based operator, has made history as the first American cannabis business to trade on the NYSE, representing a major milestone in the industry’s acceptance by regulators, investors, and the scientific community.
For decades, marijuana’s classification as a Schedule I substance under federal law created significant obstacles for cannabis companies. Despite the rapid growth of medical and recreational markets across the country, most U.S. cannabis firms were barred from major American stock exchanges and were forced to list on smaller over-the-counter markets or move to Canadian exchanges.
That landscape is now shifting. The listing comes after the federal government rescheduled medical marijuana from Schedule I to Schedule III. Schedule I drugs are defined as having no accepted medical use and high potential for abuse (including substances like heroin and LSD). Schedule III substances, by contrast, have recognized medical applications and face fewer regulatory restrictions.
While this move does not legalize cannabis federally, recreational use remains illegal at the national level, it carries important scientific and financial consequences.
Researchers have long maintained that Schedule I restrictions severely limited rigorous clinical studies on cannabis. Scientists faced heavy bureaucratic hurdles when attempting to study its medical potential, optimal dosing, long-term effects, and interactions with other drugs.
With the new classification, universities and research institutions are expected to pursue more comprehensive clinical trials. This could finally produce stronger, evidence-based data on cannabis’s effectiveness for conditions such as chronic pain, epilepsy, and various neurological disorders.
For investors, Trulieve’s NYSE listing represents a clear signal that cannabis is entering mainstream financial markets. For the scientific community, it opens the door to studies that were previously extremely difficult to conduct.
Regardless of one’s stance on marijuana legalization, it is becoming evident that the future of cannabis will be shaped increasingly by scientific research and empirical data, rather than politics alone.
A jar of Nutella aboard NASA’s Orion spacecraft has set a record for travelling farther from Earth than any of its kind.
The quirky milestone comes as Artemis II pushes deeper into space on its historic lunar mission.
Nutella just got the most badass free ad in maybe human history.
A jar of it floated across the camera on the Artemis II livestream, halfway to the Moon, completely unbothered.
All it took was zero gravity and a very good brand moment.